Digital Content 
NEWS #PharmaBuzz
27 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/27/3174505/0/en/IN8bio-Presents-T-cell-Engager-Data-Demonstrating-Deep-B-Cell-Depletion-for-Autoimmune-Indications.html
16 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/16/3168262/0/en/Cellectis-R-D-Day-Highlights-Lasme-cel-s-Potential-to-Address-Significant-Unmet-Need-for-Patients-with-r-r-B-ALL.html
15 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/amgen-skirts-50m-payout-blincyto-patent-litigation-tiff-lindis
29 Apr 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557
29 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/european-commission-approves-blincyto-in-philadelphia-chromosome-negative-cd19-positive-b-cell-precursor-acute-lymphoblastic-leukemia-in-the-consolidation-phase-302363668.html
07 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blincyto-blinatumomab-added-to-chemotherapy-significantly-improves-survival-in-newly-diagnosed-pediatric-patients-with-b-cell-precursor-acute-lymphoblastic-leukemia-b-all-302325381.html
Share 